Overview
Paradox Biosciences develops next-generation small-molecule therapeutics targeting synaptic plasticity pathways for the treatment of treatment-resistant depression and PTSD.
More in Neuropharmaceuticals
Latest industry news
Zhongke Borui Closes $15M Round to Scale Brain-Computer Interface Hardware in China
2026-11-20 ยท Funding
ALS Community Gains a Formal Voice in Brain-Computer Interface Development
2026-11-19 ยท Policy
Science Corporation Closes $400M Round to Push Brain-Computer Interface Technology Into the Clinic
2026-11-18 ยท Funding
Flourish Emerges From Stealth With Bezos and Google Ventures Backing to Advance Neuroscience
2026-11-17 ยท Funding
Company details
Category
๐ Neuropharmaceuticals
Location
San Diego, CA
Funding
Series A โ $42M
Website
paradoxbiosciences.comListed
2026-08-31
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages โ